Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Sarcoma
In a patient with an R1 resection of a chordoma who has declined proton therapy, what alternative radiation modality would you recommend?
Related Questions
How would you treat an unresectable epithelioid angiosarcoma invading the cavernous sinus, wrapping around the carotid artery?
How would you manage a recurrent meningioma of the cervical spine after resection alone?
How do you manage a spinal intramedullary metastasis following resection?
What are your top takeaways in Neuro Oncology from ASCO 2025?
How would you manage an enlarging brain metastasis that has progressed in size three months after radiosurgery?
In light of Aizer et al. data presented at ASCO 2025, what is your threshold for offering SRS/SRT in patients with multiple brain metastases?
Do you utilize tumor treating fields in patients with anaplastic pleomorphic xanthoastrocytoma (PXA) III?
Is it appropriate to use electrons to treat a fibrosarcomatous DFSP of the face s/p R1 WLE?
How would you manage an epidural spinal metastasis causing cord compression from rhabdomyosarcoma?
Do you still recommend protons for grade 2 and grade 3 glioma, following the Soprano study results showing a survival detriment?
